Project

1. PolyQ diseases (Huntington's disease & Ataxia)

- Characterization of neuronal abnormalities associated with polyQ toxicity

- Molecular mechanisms of specific neuronal abnormalities

- Development of new treatment strategy (structure-based inhibition of aggregate formation or autophagic clearance of toxic components)




Ä¡¸Å, ÆÄŲ½¼¾¾º´, ·ç°Ô¸¯º´, ÇåÆÃÅϾ¾º´ µîÀÇ ÅðÇ༺³úÁúȯµéÀº ´ëºÎºÐ µ¶¼º ´Ü¹éÁúÀÇ ÃàÀû°ú ¹ÐÁ¢ÇÑ °ü·ÃÀÌ ÀÖÀ½.

ÀÌ·¯ÇÑ µ¶¼º ´Ü¹éÁú¿¡ ÀÇÇÑ ½Å°æ¼¼Æ÷ÀÇ º¯ÇüÀ» ¿¬±¸Çϱ⿡ ¸Å¿ì ÀûÇÕÇÑ ¸ðµ¨ÀÎ PolyQ Áúº´¿¡ ´ëÇÑ µ¶ÀÚÀûÀÎ ¿¬±¸¸¦ ÅëÇØ¼­ µ¶¼º´Ü¹éÁú¿¡ ÀÇÇÑ Ãʱ⠽Ű溴¸®ÀÇ ±âÀüÀ» ±Ô¸íÇÏ´Â ¿¬±¸¸¦ ÁøÇàÁß.

Áúº´ÀÇ Èı⿡ ÁÖ·Î °üÂûµÇ´Â ½Å°æ¼¼Æ÷ÀÇ »ç¸ê¿¡ ÈξÀ ¾Õ¼­, ½ÇÁ¦ º´ÀÇ Áõ»óÀÇ ½ÃÀÛÀº Ãʱ⠴ܰ迡¼­ ½Å°æ¼¼Æ÷ÀÇ ±â´ÉÀû ÇüÅÂÀû ÀÌ»óÀ¸·ÎºÎÅÍ ½ÃÀÛµÈ´Ù°í »ý°¢µÊ.

µû¶ó¼­ ÀÌ·¯ÇÑ Æ¯ÀÌÀûÀÎ ÃÊ±â ½Å°æ º´¸® Çö»óÀ» ÀÌÇØÇÏ´Â °ÍÀº Áúº´À» Áø´ÜÇϰí, Ä¡·áÇϴµ¥ À־ ¸Å¿ì Áß¿äÇÔ.

ÀÌ·¯ÇÑ µ¶ÀÚÀûÀÎ °üÁ¡À» °¡Áö°í, ½Å°æ¼¼Æ÷ »ç¸ê¿¡ ¾Õ¼­ ½Å°æ¼¼Æ÷°¡ ¾î¶»°Ô ±â´ÉÀûÀ¸·Î ±×¸®°í ÇüÅÂÀûÀ¸·Î ¸Á°¡Á® °¡´ÂÁö¸¦ ÀÌÇØÇÏ´Â ¿¬±¸¸¦ ¼öÇàÇϰí ÀÖÀ½.


2. Cellular basis of various neurodegenerative diseases (Parkinson's disease, Alzheimer's disease, ALS, etc)

- Studying neuronal changes associated with specific alterations in intracellular components

  (Mitochondria, Endosomes, Peroxisomes, ER/Golgi, Nuclear pores, cytoskeletons)

- Development of new treatment strategies based on the specific cellular defects associated with these diseases

´Ü¹éÁú µ¶¼ºÀ̿ܿ¡µµ, ½Å°æÀÇ ³ëÈ­ ¹× ½Å°æÅðÈ­¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ´Â ¼¼Æ÷¼Ò±â°üÀÎ ¹ÌÅäÄܵ帮¾ÆÀÇ ±â´ÉÀ» ½Å°æ¼¼Æ÷ ƯÀÌÀûÀ¸·Î ¿¬±¸Çϰí ÀÖÀ½.
¼ö»óµ¹±â, Ãà»èµ¹±âÀÇ º¹ÀâÇϰí polarÇÑ ±¸Á¶¸¦ Áö´Ï°í ÀÖ´Â ½Å°æ¼¼Æ÷¿¡¼­ ·ÎÄÃÇÑ ¹ÌÅäÄܵ帮¾ÆÀÇ ±â´É ¹× ¿òÁ÷ÀÓ Á¶ÀýÀº ¸Å¿ì Áß¿äÇÏ¸ç ½ÇÁ¦ ÆÄŲ½¼¾¾º´À» Æ÷ÇÔÇÑ ´Ù¾çÇÑ Áúº´ÀÇ ÇÙ½É ¿øÀÎÁß Çϳª·Î ¿©°ÜÁü.
ÀÌ·¯ÇÑ ¹ÌÅäÄܵ帮¾ÆÀÇ ÁÖ¿ä ±â´ÉµéÀÌ ÀúÇØµÇ¾úÀ» ¶§, ´Ù¾çÇÑ ÅðÇ༺ ³úÁúȯ ¹× ½Å°æ³ëÈ­ ¸ðµ¨¿¡¼­ ¾î¶°ÇÑ º¯È­°¡ ÀÖ´ÂÁö¿¡ ´ëÇÑ Ã¼°èÀûÀÎ ¿¬±¸¸¦ ¼öÇàÁßÀÓ.

3. Neuronal maintenance and remodeling

- Studying dendritic maintenance and remodeling during aging and development


½Å°æ¼¼Æ÷´Â Çü¼º ´Ü°è»Ó¸¸ ¾Æ´Ï¶ó, º¹ÀâÇÑ ±¸Á¶¸¦ Àß À¯ÁöÇÏ°í ¸®¸ðµ¨¸µÇÏ´Â °ÍÀÌ ¸Å¿ì Áß¿äÇÔ.
ÀÌ·¯ÇÑ ½Å°æ¼¼Æ÷ÀÇ Á¦´ë·ÎµÈ ±¸Á¶Àû ¿Ï°á¼ºÀÇ À¯Áö¿Í ¸®¸ðµ¨¸µ ±âÀÛÀ» ÀÌÇØÇÏ´Â ¿¬±¸¸¦ ¼öÇàÁßÀÓ.


4. Ion & RNA Homeostasis required for neuronal maintenance









½Å°æ¼¼Æ÷´Â ¾Õ¼­ ÀûÈù´ë·Î ¸Å¿ì polarÇÑ ±¸Á¶¸¦ Áö´Ï°í Àִµ¥, cell body·ÎºÎÅÍ ¸Ö¸® ¶³¾îÁø ·ÎÄÃÇÑ ºÎÀ§¿¡ Á¦´ë·Î ´Ü¹éÁúÀ» Àü´ÞÇϱâ À§Çؼ­ mRNA transport ±â´ÉÀ» Áö´Ï°í ÀÖÀ½.
Áö±Ý±îÁö ¸¹Àº mRNA binding ´Ü¹éÁúµéÀÌ ¹àÇôÁö°í Àִµ¥, ÀÌµé °£ÀÇ Â÷ÀÌ¿Í °øÅëÁ¡, ±×¸®°í À̵éÀÌ ¼­·Î¿¡°Ô ¾î¶°ÇÑ ¿µÇâÀ» ÁÖ°í ÀÖ´ÂÁö´Â ¾ÆÁ÷ ¸¹ÀÌ ¹àÇôÁöÁö ¾Ê¾ÒÀ½.
ÀÌ·¯ÇÑ, mRNA metabolismÀ» ½Å°æ¼¼Æ÷¶ó´Â Ưº°ÇÑ ´ë»ó¿¡¼­ ¿¬±¸¸¦ Çϰí ÀÖÀ¸¸ç, ƯÈ÷ ´Ù¾çÇÑ ÅðÇ༺ ³úÁúȯ ¸ðµ¨¿¡¼­ÀÇ º´¸®±âÀü°ú ¿¬°á½ÃŰ·Á´Â ³ë·ÂÀ» Çϰí ÀÖÀ½.